Trials / Sponsors / NanoCarrier Co., Ltd.
NanoCarrier Co., Ltd.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum R SCCHN | Phase 2 | 2019-07-01 |
| Unknown | Dose-Escalation and Expansion Trial of NC-6300 in Patients With Advanced Solid Tumors or Soft Tissue Sarcoma Solid Tumor, Soft Tissue Sarcoma, Metastatic Sarcoma | Phase 1 / Phase 2 | 2017-06-30 |
| Completed | NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head a Carcinoma, Squamous Cell of Head and Neck | Phase 1 / Phase 2 | 2017-03-01 |
| Completed | Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Solid Tumors | Phase 1 / Phase 2 | 2014-05-01 |
| Completed | Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma Advanced Cancer, Lymphoma | Phase 1 | 2013-11-01 |
| Completed | NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia Locally Advanced and Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | 2009-05-01 |